Effect and safety for clearance of irritable bowel syndrome in feces through fecal microbiota transplantatio
Not Applicable
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0008616
- Lead Sponsor
- Inha University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
[1] FMT group
1. Men and women over 18 years of age
2. Patients who was finally diagnosed as irritable bowel syndrome
[2] Control group
1. Men and women over 18 years of age
2. Patients who was finally diagnosed as irritable bowel syndrome
3. FMT treatment is rejected but those who agree to participate in this study as a control group
Exclusion Criteria
1. Patients who need urgent treatment such as acute infectious diseases.
2. Patients with the disease-causing severe immunosuppression.
3. Pregnant women
4. Patients to be inappropriate for the study when judged by the researchers
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IBS .index scoring
- Secondary Outcome Measures
Name Time Method IBS .index scoring;Adverse effect;Changes of microbiome in intestine after FMT